| Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women (NCT00416975) | Virginia Commonwealth University | 2000-05-01 |
| Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health (NCT00200824) | National Center for Complementary and Integrative Health (NCCIH) | 2000-05-01 |
| Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer (NCT00031876) | Swiss Cancer Institute | 2000-05-01 |
| Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers (NCT02883985) | NYU Langone Health | 2000-05-01 |
| Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer (NCT00006261) | Case Comprehensive Cancer Center | 2000-05-01 |
| Bone Mineral Density and Subsequent Cancer Risk (NCT00340262) | National Cancer Institute (NCI) | 2000-04-07 |
| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer (NCT00005822) | Case Comprehensive Cancer Center | 2000-04-01 |
| Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer (NCT00005980) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer (NCT00416689) | Alliance for Clinical Trials in Oncology | 2000-04-01 |
| Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer (NCT00005957) | NCIC Clinical Trials Group | 2000-03-09 |
| Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density. (NCT00188682) | University Health Network, Toronto | 2000-03-01 |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (NCT00017537) | University of Alabama at Birmingham | 2000-03-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer (NCT00983684) | University College, London | 2000-03-01 |
| Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes (NCT00668616) | North Eastern German Society of Gynaecological Oncology | 2000-03-01 |
| Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer (NCT00031850) | Institute of Cancer Research, United Kingdom | 2000-03-01 |
| Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer (NCT00943410) | UNC Lineberger Comprehensive Cancer Center | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer (NCT00006032) | H. Lee Moffitt Cancer Center and Research Institute | 2000-03-01 |
| Susceptibility to Breast Cancer (NCT00004565) | National Cancer Institute (NCI) | 2000-02-08 |
| Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer (NCT00005605) | Northwestern University | 2000-02-01 |
| Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer (NCT00005608) | Northwestern University | 2000-02-01 |
| Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer (NCT00006682) | Medstar Health Research Institute | 2000-02-01 |
| Biological Therapy in Treating Patients With Advanced Cancer (NCT00005956) | Duke University | 2000-02-01 |
| Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer (NCT00096291) | Massachusetts General Hospital | 2000-02-01 |
| Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer (NCT00096369) | University of Texas Southwestern Medical Center | 2000-02-01 |
| Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer (NCT00647218) | Vanderbilt-Ingram Cancer Center | 2000-02-01 |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 (NCT00004067) | NSABP Foundation Inc | 2000-02-01 |
| Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer (NCT00008034) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-02-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| Oncologic Outcomes of Minimal Access Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer (NCT07069803) | Changhua Christian Hospital | 2000-02-01 |
| Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer (NCT00010075) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2000-01-01 |
| Analysis of Breast-Conserving Surgery Plus Whole-Breast Irradiation Versus Mastectomy (NCT05126667) | European Institute of Oncology | 2000-01-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer (NCT00012311) | Herbert Irving Comprehensive Cancer Center | 2000-01-01 |
| Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer (NCT00213980) | University of Wisconsin, Madison | 2000-01-01 |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer (NCT00022230) | Roger Williams Medical Center | 2000-01-01 |
| Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 (NCT00005635) | Genentech, Inc. | 2000-01-01 |
| Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer (NCT00022204) | Royal Marsden NHS Foundation Trust | 2000-01-01 |
| Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer (NCT00006433) | National Center for Research Resources (NCRR) | 2000-01-01 |
| Docetaxel in Treating Patients With Metastatic Breast Cancer (NCT00008411) | M.D. Anderson Cancer Center | 1999-12-01 |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (NCT00004261) | University Health Network, Toronto | 1999-12-01 |
| Vinorelbine and XR9576 to Treat Cancer (NCT00001944) | National Cancer Institute (NCI) | 1999-12-01 |
| Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer (NCT00004893) | Alliance for Clinical Trials in Oncology | 1999-12-01 |
| Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ (NCT00003857) | Radiation Therapy Oncology Group | 1999-12-01 |
| Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes (NCT00004125) | Eastern Cooperative Oncology Group | 1999-11-16 |
| Comparison of Two Types of Biopsy in Patients With Breast Lesions (NCT00006031) | H. Lee Moffitt Cancer Center and Research Institute | 1999-11-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer (NCT00006225) | Northwestern University | 1999-11-01 |
| Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer (NCT00129922) | Spanish Breast Cancer Research Group | 1999-11-01 |
| Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer (NCT00014430) | Dartmouth-Hitchcock Medical Center | 1999-11-01 |
| Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer (NCT00004172) | Northwestern University | 1999-10-01 |
| Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer (NCT00004182) | Northwestern University | 1999-10-01 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer (NCT00004174) | Northwestern University | 1999-10-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer (NCT00004906) | Hackensack Meridian Health | 1999-10-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer (NCT00004900) | Hackensack Meridian Health | 1999-10-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery (NCT00006126) | Northwestern University | 1999-09-01 |
| Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00005873) | Astex Pharmaceuticals, Inc. | 1999-09-01 |
| Effects of Raloxifene on Hormone Levels (NCT00026962) | National Cancer Institute (NCI) | 1999-09-01 |
| Facilitating Positive Adaptation to Breast Cancer (NCT01422551) | University of Miami | 1999-09-01 |
| Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast (NCT00898937) | Georgetown University | 1999-09-01 |
| Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 (NCT00004935) | Swiss Cancer Institute | 1999-08-30 |
| Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer (NCT00006108) | UNC Lineberger Comprehensive Cancer Center | 1999-08-01 |
| Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer (NCT00004925) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma (NCT00005590) | Cancer Research Campaign Clinical Trials Centre | 1999-08-01 |
| Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 (NCT00019812) | National Institutes of Health Clinical Center (CC) | 1999-08-01 |
| Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 (NCT00003992) | National Cancer Institute (NCI) | 1999-08-01 |
| Management of Metastatic Breast Cancer in Frail Patients (NCT00005614) | H. Lee Moffitt Cancer Center and Research Institute | 1999-08-01 |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00004095) | Northwestern University | 1999-08-01 |
| Study of Etoposide in Breast Cancer Patients (NCT00026949) | National Cancer Institute (NCI) | 1999-08-01 |
| Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease (NCT00200174) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer (NCT00588029) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer (NCT00724386) | University of Chicago | 1999-06-01 |
| MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer (NCT00003736) | Abramson Cancer Center at Penn Medicine | 1999-06-01 |
| Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid (NCT00295646) | Austrian Breast & Colorectal Cancer Study Group | 1999-06-01 |
| Chemotherapy in Treating Women With Metastatic Breast Cancer (NCT00004046) | Daiichi Sankyo | 1999-06-01 |
| Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child (NCT00194571) | University of Washington | 1999-06-01 |
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer (NCT00003927) | City of Hope Medical Center | 1999-05-18 |
| Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer (NCT00005993) | Masonic Cancer Center, University of Minnesota | 1999-05-01 |
| Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer (NCT00004092) | City of Hope Medical Center | 1999-05-01 |
| Vaccine Therapy in Treating Patients With Breast Cancer (NCT00004156) | Memorial Sloan Kettering Cancer Center | 1999-05-01 |
| Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women (NCT00003906) | NSABP Foundation Inc | 1999-05-01 |
| Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer (NCT00003830) | NSABP Foundation Inc | 1999-05-01 |
| Irofulven in Treating Patients With Metastatic Breast Cancer (NCT00003796) | National Cancer Institute (NCI) | 1999-05-01 |
| Methods in Education for Breast Cancer Genetics (NCT00001806) | National Cancer Institute (NCI) | 1999-04-06 |
| Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer (NCT00003855) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer (NCT00005800) | H. Lee Moffitt Cancer Center and Research Institute | 1999-04-01 |
| Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00003612) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer (NCT00003854) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00003761) | Dana-Farber Cancer Institute | 1999-03-03 |
| Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer (NCT00005023) | University of Washington | 1999-03-01 |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer (NCT00136539) | Harold J. Burstein, MD, PhD | 1999-03-01 |
| Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement (NCT00003902) | Swiss Cancer Institute | 1999-03-01 |
| Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes (NCT00003782) | NSABP Foundation Inc | 1999-03-01 |
| Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer (NCT00009997) | NYU Langone Health | 1999-03-01 |
| Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer (NCT00003953) | Case Comprehensive Cancer Center | 1999-02-01 |
| Extended Follow-up of Columbia, MO Serum Bank Participants (NCT00340210) | National Cancer Institute (NCI) | 1999-01-14 |
| Vaccine Therapy in Treating Women With Metastatic Breast Cancer (NCT00003638) | Oncothyreon Canada Inc. | 1999-01-01 |
| Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer (NCT00004038) | National Cancer Institute (NCI) | 1999-01-01 |
| A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer (NCT00190489) | Japan Clinical Oncology Group | 1999-01-01 |